Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
$0.00
$0.00
$0.00
▼
$0.00
N/A1.4439 shsN/A
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
C$15.75
C$15.75
C$7.94
▼
C$15.75
N/AN/A3,550 shsN/A
ADB International Group Inc. stock logo
EQUR
ADB International Group
$0.00
$0.00
$0.00
▼
$0.05
N/AN/AN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
$219.88
-4.0%		$210.47
$178.30
▼
$264.30
N/AN/A2,030 shs12 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
0.00%0.00%0.00%0.00%+400.00%
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
0.00%0.00%0.00%0.00%+98.36%
ADB International Group Inc. stock logo
EQUR
ADB International Group
0.00%0.00%0.00%0.00%0.00%
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
-3.98%-3.98%+8.85%+7.02%+9.25%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
$0.00
$0.00
$0.00
▼
$0.00
N/A1.4439 shsN/A
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
C$15.75
C$15.75
C$7.94
▼
C$15.75
N/AN/A3,550 shsN/A
ADB International Group Inc. stock logo
EQUR
ADB International Group
$0.00
$0.00
$0.00
▼
$0.05
N/AN/AN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
$219.88
-4.0%		$210.47
$178.30
▼
$264.30
N/AN/A2,030 shs12 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
0.00%0.00%0.00%0.00%+400.00%
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
0.00%0.00%0.00%0.00%+98.36%
ADB International Group Inc. stock logo
EQUR
ADB International Group
0.00%0.00%0.00%0.00%0.00%
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
-3.98%-3.98%+8.85%+7.02%+9.25%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
0.00
N/AN/AN/A
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
0.00
N/AN/AN/A
ADB International Group Inc. stock logo
EQUR
ADB International Group
0.00
N/AN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
2.67
Moderate BuyN/AN/A

Current Analyst Ratings Breakdown

Latest SDMHF, EQUR, ADDLF, and ABMT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/20/2026
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeBuy
(Data available from 9/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
N/AN/AN/AN/AN/AN/A
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/AN/AN/AN/AN/AN/A
ADB International Group Inc. stock logo
EQUR
ADB International Group
N/AN/AN/AN/AN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
N/AN/AN/AN/AN/AN/AN/AN/AN/A
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/AN/A
ADB International Group Inc. stock logo
EQUR
ADB International Group
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
N/A$4.3151.02N/AN/AN/AN/AN/A10/22/2026 (Estimated)
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
N/AN/AN/AN/AN/A
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/AN/AN/AN/AN/A
ADB International Group Inc. stock logo
EQUR
ADB International Group
N/AN/AN/AN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
$1.200.55%N/A27.84%N/A

Institutional Ownership

CompanyInstitutional Ownership
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
N/A
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/A
ADB International Group Inc. stock logo
EQUR
ADB International Group
N/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
9.21%

Insider Ownership

CompanyInsider Ownership
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
34.11%
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/A
ADB International Group Inc. stock logo
EQUR
ADB International Group
79.63%
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
20N/AN/ANot Optionable
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
2,289N/AN/ANot Optionable
ADB International Group Inc. stock logo
EQUR
ADB International Group
1N/AN/ANot Optionable
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
10,382N/AN/ANot Optionable

Recent News About These Companies

Sartorius Stedim Biotech SA SDMHF
September 4, 2026  |  morningstar.comM
Sartorius Stedim stock steadies above EUR 195 as Q2 2026 revenue trails forecasts
August 29, 2026  |  ad-hoc-news.deA
RBC Capital Sticks to Its Hold Rating for Sartorius Stedim Biotech (0RG8)
February 13, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/61764/rbc-capital-sticks-to-its-hold-rating-for-sartorius-stedim-biotech-0rg8/
Sartorius Stedim Biotech S.A. (SRTOY) Q4 2025 Earnings Call Transcript
February 3, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4865340-sartorius-stedim-biotech-s-a-srtoy-q4-2025-earnings-call-transcript
Goldman Sachs downgrades Sartorius Stedim to “neutral” after late-2025 rally
January 12, 2026  |  ca.investing.comhttps://ca.investing.com/news/stock-market-news/goldman-sachs-downgrades-sartorius-stedim-to-neutral-after-late2025-rally-4396523
Sartorius Stedim price target raised to EUR 260 from EUR 225 at JPMorgan
December 8, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/sartorius-stedim-price-target-raised-to-eur-260-from-eur-225-at-jpmorgan/ar-AA1RXi6x
Sartorius Stedim Biotech invests in Nanotein Technologies to help scale up cell therapy solutions
August 13, 2025  |  chemengonline.comC
Sartorius Stedim Biotech & Nanotein Technologies partner to advance cell therapy manufacturing
August 13, 2025  |  pharmabiz.comP
Sartorius to invest $3m for minority share in biotech start-up Nanotein
August 12, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/sartorius-to-invest-3m-for-minority-share-in-biotech-start-up-nanotein/ar-AA1KoPs9
Sartorius Stedim Biotech and Nanotein Technologies Partner to Advance Cell Therapy Manufacturing
August 11, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250811343687/en/sartorius-stedim-biotech-and-nanotein-technologies-partner-to-advance-cell-therapy-manufacturing/
Bio Usawa and Sartorius Stedim Biotech forge partnership to pioneer biopharmaceutical manufacturing in Africa
August 3, 2025  |  chemengonline.comC
Bio Usawa Biotechnology and Sartorius Stedim Biotech Forge Partnership to Pioneer Biopharmaceutical Manufacturing in Africa
July 29, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/29/3123398/0/en/bio-usawa-biotechnology-and-sartorius-stedim-biotech-forge-partnership-to-pioneer-biopharmaceutical-manufacturing-in-africa.html
Sartorius Stedim Biotech S.A. (SDMHF) - Yahoo Finance
June 27, 2025  |  au.finance.yahoo.comhttps://au.finance.yahoo.com/quote/SDMHF/
Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess solutions in France
June 17, 2025  |  pharmiweb.comP
Kepler Capital Reaffirms Their Hold Rating on Sartorius Stedim Biotech (0RG8)
April 26, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/kepler-capital-reaffirms-their-hold-rating-on-sartorius-stedim-biotech-0rg8-1034629120
Earnings call transcript: Sartorius Stedim Biotech beats Q1 2025 expectations
April 18, 2025  |  uk.investing.comhttps://uk.investing.com/news/transcripts/earnings-call-transcript-sartorius-stedim-biotech-beats-q1-2025-expectations-93CH-4033346
Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
March 25, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/resolutions-of-the-combined-annual-shareholders-8217-meeting-of-sartorius-stedim-biotech-s-a-1034511959
Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting
February 7, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/board-of-directors-of-sartorius-stedim-biotech-resolves-to-propose-dividend-of-0-69-euros-per-share-to-annual-shareholders-8217-meeting-1034328064
Kepler Capital Sticks to Its Hold Rating for Sartorius Stedim Biotech (0RG8)
January 31, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/kepler-capital-sticks-to-its-hold-rating-for-sartorius-stedim-biotech-0rg8-1034292287
Sartorius Stedim Biotech SA (SDMHF) Q4 2024 Earnings Call Highlights: Navigating Growth Amid ...
January 31, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/sartorius-stedim-biotech-sa-sdmhf-070443566.html

Media Sentiment Over Time

Advanced Biomedical Technologies stock logo

Advanced Biomedical Technologies OTCMKTS:ABMT

$0.0005 0.00 (0.00%)
As of 09/8/2026

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

AddLife AB (publ) stock logo

AddLife AB (publ) OTCMKTS:ADDLF

C$15.75 0.00 (0.00%)
As of 09/8/2026

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.

ADB International Group stock logo

ADB International Group OTCMKTS:EQUR

$0.0002 0.00 (0.00%)
As of 10/5/2023

E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.

Sartorius Stedim Biotech stock logo

Sartorius Stedim Biotech OTCMKTS:SDMHF

$219.88 -9.12 (-3.98%)
As of 09/10/2026 12:21 PM Eastern

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas